Sale by Hong Zhao of 12500 shares of SciClone Pharmaceuticals
SciClone Pharmaceuticals Inc insider trading alert for sale of common stock by Hong Zhao, CEO China Operations, on January 3, 2018. This event was filed by Sciclone Pharmaceuticals with SEC on 2017-06-14. Statement of changes in beneficial ownership - SEC Form 4
Filed transaction by Sciclone Pharmaceuticals officer. General open market or private sale of non-derivative or derivative security
Story MomentumThis story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.
Similar stores for SciClone Pharmaceuticals